Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 19.9526 | uM | 7 | 1250.00 | 859.67 | 889.00 | 1832.08 | 0.4858 | 0.0244 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 7 | 2500.00 | 1881.33 | 3801.67 | 3750.83 | 1.0133 | 1.0259 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 2500.00 | 1881.33 | 3672.67 | 3750.83 | 0.9777 | 0.9505 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 7 | 2500.00 | 1881.33 | 3845.00 | 3750.83 | 1.0241 | 1.0457 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 2500.00 | 1881.33 | 3849.00 | 3750.83 | 1.0276 | 1.0604 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 7 | 2500.00 | 1881.33 | 3892.67 | 3750.83 | 1.0387 | 1.0806 |
| SK-BR-3 | Erlotinib | 1 | uM | 7 | 2500.00 | 1881.33 | 3766.00 | 3750.83 | 1.0030 | 1.0028 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 7 | 2500.00 | 1881.33 | 3225.00 | 3750.83 | 0.8590 | 0.7138 |
| SK-BR-3 | Erlotinib | 10 | uM | 7 | 2500.00 | 1881.33 | 2079.33 | 3750.83 | 0.5546 | 0.1050 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 7 | 2500.00 | 1881.33 | 2065.33 | 3750.83 | 0.5507 | 0.0970 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 7 | 5000.00 | 1699.69 | 5694.00 | 5670.58 | 1.0042 | 1.0050 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 5000.00 | 1699.69 | 5733.33 | 5670.58 | 1.0111 | 1.0128 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 7 | 5000.00 | 1699.69 | 5506.33 | 5670.58 | 0.9690 | 0.9600 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 5000.00 | 1699.69 | 5634.00 | 5670.58 | 0.9929 | 0.9910 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 7 | 5000.00 | 1699.69 | 5794.33 | 5670.58 | 1.0222 | 1.0258 |
| SK-BR-3 | Erlotinib | 1 | uM | 7 | 5000.00 | 1699.69 | 5434.00 | 5670.58 | 0.9565 | 0.9460 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 7 | 5000.00 | 1699.69 | 5495.33 | 5670.58 | 0.9689 | 0.9637 |
| SK-BR-3 | Erlotinib | 10 | uM | 7 | 5000.00 | 1699.69 | 3595.67 | 5670.58 | 0.6340 | 0.5383 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 7 | 5000.00 | 1699.69 | 3404.33 | 5670.58 | 0.6003 | 0.4909 |
| BT-20 | Erlotinib | 0.0033113 | uM | 8 | 156.25 | 28.44 | 102.67 | 91.42 | 1.1160 | 1.1198 |
| BT-20 | Erlotinib | 0.01 | uM | 8 | 156.25 | 28.44 | 105.67 | 91.42 | 1.1544 | 1.1636 |
| BT-20 | Erlotinib | 0.031623 | uM | 8 | 156.25 | 28.44 | 151.33 | 91.42 | 1.6625 | 1.7036 |
| BT-20 | Erlotinib | 0.1 | uM | 8 | 156.25 | 28.44 | 159.33 | 91.42 | 1.7651 | 1.8181 |
| BT-20 | Erlotinib | 0.31623 | uM | 8 | 156.25 | 28.44 | 121.00 | 91.42 | 1.3128 | 1.3329 |
| BT-20 | Erlotinib | 1 | uM | 8 | 156.25 | 28.44 | 126.33 | 91.42 | 1.3797 | 1.4079 |